# Combination 5-FU / Calcipotriene Cream for SCCIS/SCC

> **NCT04839731** · EARLY_PHASE1 · UNKNOWN · sponsor: **Carilion Clinic** · enrollment: 30 (estimated)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** Combination topical 5-fluorouracil 5% / calcipotriene 0.005% cream
- **DRUG:** Nourivan Base Cream

## Key facts

- **NCT ID:** NCT04839731
- **Lead sponsor:** Carilion Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-14
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04839731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04839731, "Combination 5-FU / Calcipotriene Cream for SCCIS/SCC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04839731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*